Información del producto
SKLB 610 is a potential anticancer agent that inhibits tumor growth. SKLB 610 has shown potent inhibitory activity in both cell culture and animal models. It has been shown to inhibit the proliferation of tumor cells and reduce the number of vessels in the tumor, which may be due to its ability to adsorb onto the cell membrane and alter the distribution of nutrients. SKLB 610 is a biopharmaceutical that is delivered as a particle, which may allow for higher bioavailability. This drug has also been shown to have potent inhibitory effects on cellular growth factor pathways.